BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17400506)

  • 1. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.
    Ross OA; Haugarvoll K; Stone JT; Heckman MG; White LR; Aasly JO; Mark Gibson J; Lynch T; Wszolek ZK; Uitti RJ; Farrer MJ
    Parkinsonism Relat Disord; 2007 Oct; 13(7):386-8. PubMed ID: 17400506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.
    Sutherland G; Mellick G; Sue C; Chan DK; Rowe D; Silburn P; Halliday G
    Neurosci Lett; 2007 Mar; 414(2):170-3. PubMed ID: 17280783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for association of a parkin promoter polymorphism with early-onset Parkinson's disease in a Chinese population.
    Taylor JM; Wu RM; Lin CH; Delatycki MB; Lockhart PJ
    Parkinsonism Relat Disord; 2009 Feb; 15(2):149-52. PubMed ID: 18387843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations.
    Ghazavi F; Fazlali Z; Banihosseini SS; Hosseini SR; Kazemi MH; Shojaee S; Parsa K; Sadeghi H; Sina F; Rohani M; Shahidi GA; Ghaemi N; Ronaghi M; Elahi E
    Mov Disord; 2011 Jan; 26(1):80-9. PubMed ID: 21322020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional parkin promoter polymorphism in Parkinson's disease: new data and meta-analysis.
    Chang XL; Mao XY; Li HH; Zhang JH; Li NN; Burgunder JM; Peng R; Tan EK
    J Neurol Sci; 2011 Mar; 302(1-2):68-71. PubMed ID: 21176923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
    Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
    Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
    Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
    González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
    Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
    Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
    Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.
    Wu RM; Bounds R; Lincoln S; Hulihan M; Lin CH; Hwu WL; Chen J; Gwinn-Hardy K; Farrer M
    Arch Neurol; 2005 Jan; 62(1):82-7. PubMed ID: 15642853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
    Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.
    Dächsel JC; Mata IF; Ross OA; Taylor JP; Lincoln SJ; Hinkle KM; Huerta C; Ribacoba R; Blazquez M; Alvarez V; Farrer MJ
    Neurosci Lett; 2006 Dec; 410(2):80-4. PubMed ID: 17095157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.
    Wiley J; Lynch T; Lincoln S; Skipper L; Hulihan M; Gosal D; Bisceglio G; Kachergus J; Hardy J; Farrer MJ
    Mov Disord; 2004 Jun; 19(6):677-81. PubMed ID: 15197707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.
    Peng R; Gou Y; Yuan Q; Li T; Latsoudis H; Yuan G; Luo D; Liu X; Collier DA
    Eur Neurol; 2003; 49(2):85-9. PubMed ID: 12584415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in the promoter region of the PARKIN gene and Parkinson's disease.
    Mata IF; Alvarez V; García-Moreira V; Guisasola LM; Ribacoba R; Salvador C; Blázquez M; Sarmiento RG; Lahoz CH; Menes BB; García EC
    Neurosci Lett; 2002 Aug; 329(2):149-52. PubMed ID: 12165399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
    Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
    Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin gene variations in late-onset Parkinson's disease: comparison between Norwegian and German cohorts.
    Schlitter AM; Kurz M; Larsen JP; Woitalla D; Müller T; Epplen JT; Dekomien G
    Acta Neurol Scand; 2006 Jan; 113(1):9-13. PubMed ID: 16367892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
    Ghione I; Di Fonzo A; Saladino F; Del Bo R; Bresolin N; Comi GP; Rango M
    Neurotoxicology; 2007 May; 28(3):698-701. PubMed ID: 17335904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association analysis of the parkin gene in patients with sporadic Parkinson's disease from a Han population of Sichuan province].
    Peng R; Chen WJ; Wu Y; Liu M; Lai XH; Zhang JH; Yuan GG; Gou YR; Li T; Wang YC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):38-41. PubMed ID: 17285542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.